Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cell cytotoxicity via natural killer cell-mediated lysis refers to the process through which NK cells, a subset of cytotoxic lymphocytes, recognize and rapidly destroy tumor cells without prior sensitization. NK cells exert their effects through two major mechanisms: the release of cytolytic granules (containing perforin and granzymes, leading to apoptosis or cell lysis) and engagement of death receptor pathways via ligands such as Fas ligand and TRAIL. In addition, NK cells can mediate antibody-dependent cellular cytotoxicity (ADCC), recognizing tumor cells opsonized by specific monoclonal antibodies. This process is central to immune surveillance against cancer and is exploited in several immunotherapies. Rather than a single molecular target, the process involves multiple receptors, signaling proteins, and effector molecules that coordinate the recognition and killing of aberrant cells[1][2][3][4][5][7][8].
Antibody-dependent cell-mediated cytotoxicity (by engaging NK cells through Fc receptors); Direct NK cell activation and cytolytic granule release (perforin, granzyme); Death receptor ligand-induced apoptosis (Fas ligand, TRAIL)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell cytotoxicity via natural killer cell-mediated lysis.